Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Mucosal Melanoma × camrelizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Gastric Adenocarcinoma 2 Solid Tumor 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 NSCLC 1 Mucosal Melanoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Diseases 1 Drug-Related Side Effects and Adverse Reactions 1 Digestive System Neoplasms 1 Breast Neoplasms 1

Interventions

camrelizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03986515 2019-06-14

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Henan Cancer Hospital

Phase 2 Unknown

Mucosal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡